Skip to content
value.today

Thrive Bioscience, Inc.

🇺🇸 Beverly, Massachusetts, USABiotechnologyFounded 2014
Total raised
$14 M
4 rounds on record
Latest round
$2 M
May 2017
First round on record
Apr 2015
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Thrive Bioscience, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2017$2 MNo. 4Under $2 million

Thrive Bioscience, Inc.: Raise no. 4, May 2017

Investors in this round

21 investors had bought by the notice of Aug 28, 2017: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
$100,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$264,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alan Philippe Blanchard · Executive Officer, Director
  • Thomas Forest Farb · Executive Officer, Director
  • Brock Philippe Reeve · Director
  • Guy Philippe Broadbent · Director
  • Michael Philippe Finney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas Forest Farb, President. Source: SEC Form D, newest notice filed Aug 28, 2017. Read the notice at the SEC.

debt, optionsSEC
Dec 2016$7 MNo. 3$2 to $10 million

Thrive Bioscience, Inc.: Raise no. 3, Dec 2016

Investors in this round

36 investors had bought by the notice of Mar 7, 2017: 36 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $10 M offered; $3 M still to sell
Smallest investment taken
$7,500
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$760,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alan Philippe Blanchard · Executive Officer, Director
  • Thomas Forest Farb · Executive Officer, Director
  • Brock Philippe Reeve · Director
  • Guy Philippe Broadbent · Director
  • Michael Philippe Finney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas Forest Farb, President. Source: SEC Form D, newest notice filed Mar 7, 2017. Read the notice at the SEC.

equitySEC
Nov 2015$2 MNo. 2$2 to $10 million

Thrive Bioscience, Inc.: Raise no. 2, Nov 2015

Investors in this round

20 investors had bought by the notice of Dec 11, 2015: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$7,500
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$350,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Massachusetts

People named in the notice

  • Alan Philippe Blanchard · Executive Officer, Director
  • Thomas Forest Farb · Executive Officer, Director
  • Brock Philippe Reeve · Director
  • Guy Philippe Broadbent · Director
  • Michael Philippe Finney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas Forest Farb, President & CEO. Source: SEC Form D, newest notice filed Dec 11, 2015. Read the notice at the SEC.

debt, optionsSEC
Apr 2015$3 MNo. 1$2 to $10 million

Thrive Bioscience, Inc.: Raise no. 1, Apr 2015

Investors in this round

24 investors had bought by the notice of May 15, 2015: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
$20,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$285,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Massachusetts

People named in the notice

  • Alan Philippe Blanchard · Executive Officer, Director
  • Gary Paul Magnant · Executive Officer, Director
  • Thomas Forest Farb · Executive Officer, Director
  • Michael Forest Finney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas Forest Farb, Coo & cfo. Source: SEC Form D, newest notice filed May 15, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Thrive Bioscience, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2017).

    SEC Form D · Aug 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2017

That is all the official record says: Thrive Bioscience, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Thrive Bioscience, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 36 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Thrive Bioscience, Inc.
NameRoleNamed in
Alan Philippe BlanchardExecutive officerAug 2017
Thomas Forest FarbExecutive officerAug 2017
Gary Paul MagnantExecutive officerMay 2015
Alan Philippe BlanchardDirectorAug 2017
Brock Philippe ReeveDirectorAug 2017
Guy Philippe BroadbentDirectorAug 2017
Michael Philippe FinneyDirectorAug 2017
Thomas Forest FarbDirectorAug 2017
Gary Paul MagnantDirectorMay 2015
Michael Forest FinneyDirectorMay 2015